These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7745108)

  • 1. Specific increase in interleukin-8 concentrations in dialysis fluid of patients with peritonitis receiving continuous ambulatory peritoneal dialysis.
    Ko YC; Mukaida N; Kasahara T; Muto S; Matsushima K; Kusano E; Asano Y; Itoh Y; Yamagishi Y; Kawai T
    J Clin Pathol; 1995 Feb; 48(2):115-9. PubMed ID: 7745108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6 and interleukin-8 in dialysate and serum from patients on continuous ambulatory peritoneal dialysis.
    Brauner A; Hylander B; Wretlind B
    Am J Kidney Dis; 1993 Sep; 22(3):430-5. PubMed ID: 8372840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis.
    Brauner A; Hylander B; Wretlind B
    Am J Kidney Dis; 1996 Mar; 27(3):402-8. PubMed ID: 8604710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis?
    Cueto-Manzano AM; Rojas-Campos E; Martínez-Ramírez HR; Valera-González I; Medina M; Monteón F; Ruiz N; Becerra M; Palomeque MA; Cortés-Sanabria L
    Perit Dial Int; 2006; 26(3):341-8. PubMed ID: 16722027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-8 in chronic renal failure and dialysis patients.
    Nakanishi I; Moutabarrik A; Okada N; Kitamura E; Hayashi A; Syouji T; Namiki M; Ishibashi M; Zaid D; Tsubakihara Y
    Nephrol Dial Transplant; 1994; 9(10):1435-42. PubMed ID: 7816257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial cytokine changes in peritoneal effluent and plasma during peritonitis in patients on continuous ambulatory peritoneal dialysis (CAPD).
    Kozioł-Montewka M; Ksiazek A; Janicka L; Baranowicz I
    Inflamm Res; 1997 Apr; 46(4):132-6. PubMed ID: 9137991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic and intraperitoneal proinflammatory cytokines profiles in patients on chronic peritoneal dialysis.
    Maksić D; Colić M; Stanković-Popović V; Radojević M; Bokonjić D
    Med Pregl; 2007; 60 Suppl 2():53-7. PubMed ID: 18928158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-8 during peritonitis in patients treated with CAPD; an in-vivo model of acute inflammation.
    Zemel D; Krediet RT; Koomen GC; Kortekaas WM; Geertzen HG; ten Berge RJ
    Nephrol Dial Transplant; 1994; 9(2):169-74. PubMed ID: 8190331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritonitis in continuous ambulatory peritoneal dialysis: cytokines in peritoneal fluid and blood.
    Enríquez J; Klínger J; Arturo JA; Delgado M; Tobar C; Mosquera M
    Adv Perit Dial; 2002; 18():177-83. PubMed ID: 12402614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship.
    Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S
    Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic and intraperitoneal proinflammatory cytokine profiles in patients on continuous ambulatory peritoneal dialysis.
    Maksic D; Vasilijic S; Colic M; Stankovic-Popovic V; Bokonjic D
    Adv Perit Dial; 2009; 25():50-5. PubMed ID: 19886317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis.
    Zemel D; Koomen GC; Hart AA; ten Berge IJ; Struijk DG; Krediet RT
    J Lab Clin Med; 1993 Dec; 122(6):686-96. PubMed ID: 8245688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokines and peritonitis in continuous ambulatory peritoneal dialysis: immunodeviation and immunodeficiency.
    Klínger J; Enríquez J; Arturo JA; Delgado M; Avila G; Ceballos O
    Adv Perit Dial; 2002; 18():170-6. PubMed ID: 12402613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial changes of interleukin-6 and interleukin-8 levels in drain dialysate of uremic patients with continuous ambulatory peritoneal dialysis during peritonitis.
    Lin CY; Lin CC; Huang TP
    Nephron; 1993; 63(4):404-8. PubMed ID: 8459875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1 and its naturally occurring antagonist in peritoneal dialysis patients.
    Moutabarrik A; Nakanishi I; Namiki M; Tsubakihara Y
    Clin Nephrol; 1995 Apr; 43(4):243-8. PubMed ID: 7606878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma interleukin-6 levels in continuous ambulatory peritoneal dialysis and hemodialysis patients.
    Nakahama H; Tanaka Y; Shirai D; Miyazaki M; Imai N; Yokokawa T; Okada M; Kubori S
    Nephron; 1992; 61(2):132-4. PubMed ID: 1630534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-10, interferon gamma, interleukin-2, and soluble interleukin-2 receptor alpha detected during peritonitis in the dialysate and serum of patients on continuous ambulatory peritoneal dialysis.
    Lu Y; Hylander B; Brauner A
    Perit Dial Int; 1996; 16(6):607-12. PubMed ID: 8981529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired initial cell reaction in CAPD-related peritonitis.
    Koopmans JG; Boeschoten EW; Pannekeet MM; Betjes MG; Zemel D; Kuijper EJ; Krediet RT
    Perit Dial Int; 1996; 16 Suppl 1():S362-7. PubMed ID: 8728224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopolysaccharide binding protein: a marker for intraperitoneal bacterial infection in patients with CAPD peritonitis.
    Schäfer K; Schumann RR; Stöteknuel S; Böhler J; Schollmeyer P; Dobos GJ
    Adv Perit Dial; 1997; 13():210-3. PubMed ID: 9360683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2 inhibits the release of tumor necrosis factor-alpha, rather than interleukin 1 beta, from human macrophages.
    Fieren MW; van den Bemd GJ; Ben-Efraim S; Bonta IL
    Immunol Lett; 1992 Jan; 31(1):85-90. PubMed ID: 1548034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.